Assessment of ANAVEX 2-73 in a MECP2 Rett Syndrome Mouse ModelFeb 26, 20162016 Epilepsy Pipeline Conference, San Francisco, California Christopher U. Missling, PhD View Presentation
2016 Epilepsy Pipeline Conference, San Francisco, California Christopher U. Missling, PhD View Presentation
Anavex Life Sciences Reports Fiscal 2025 First Quarter Financial Results and Provides Business Update
Anavex Life Sciences to Announce Fiscal 2025 First Quarter Financial Results on Wednesday, February 12, 2025
